Bayer Patent Invalidated Due To Obviousness

Law360, New York (March 4, 2008, 12:00 AM EST) -- The federal court overseeing Bayer Schering Pharma AG's patent suit against Barr Laboratories Inc. over the $488 million U.S. market for the contraceptive Yasmin has declared the patent at issue invalid due to obviousness and dismissed the lawsuit with prejudice.

U.S. District Judge Peter G. Sheridan of the U.S. District Court for the District of New Jersey issued an order Monday dismissing the case and holding that the asserted claims of the patent in suit were invalid because they would have been obvious to a person...
To view the full article, register now.